RecruitingNCT01885299

RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT

Multi-Institution Registry of SRS/SBRT Procedures

Sponsor

The Radiosurgery Society

Enrollment

50,000 participants

Start Date

Mar 1, 2012

Study Type

OBSERVATIONAL

Conditions

Neoplasms Arteriovenous Malformation of Central Nervous System Trigeminal Neuralgia

Summary

The RSSearch® Registry is an international multi-year database designed to track SRS/SBRT (Stereotactic Radiosurgery/Stereotactic Body Radiation Therapy) utilization, treatment practices and outcomes to help determine, over time, the most effective use of these systems in management of patients with life threatening tumors and other diseases. (This study was formally called ReCKord and included the CyberKnife only; The ReCKord study continues as a CyberKnife subset of RSSearch.)

Eligibility

Plain Language Summary

Simplified for easier understanding

This registry study collects long-term follow-up data from patients who have received stereotactic radiosurgery (SRS) or stereotactic body radiotherapy (SBRT) — highly precise, focused radiation treatments — for tumors or other conditions, to help researchers understand outcomes over time. **You may be eligible if...** - You have been diagnosed with a benign or malignant tumor, or another condition being treated with stereotactic radiosurgery or SBRT - You are willing to sign a consent form or verbally agree to participate **You may NOT be eligible if...** - You are unwilling to sign the consent form or decline to participate Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

RADIATIONSRS/SBRT

Intervention varies by condition being treated.

Locations(13)

Penrose Cancer Center

Colorado Springs, Colorado, United States

Sylvester Comprehensive Cancer Center, University of Miami

Miami, Florida, United States

Southeast Georgia Health System

Brunswick, Georgia, United States

Henry Ford Health System

Detroit, Michigan, United States

AtlantiCare Regional Medical Center and AtlantiCare Cancer Care Institute

Egg Harbor, New Jersey, United States

Riverview Medical Center

Red Bank, New Jersey, United States

NJ Cyberknife at Community Medical Center

Toms River, New Jersey, United States

Montefiore Medical Center

The Bronx, New York, United States

Geisinger Health System

Danville, Pennsylvania, United States

Philadelphia CyberKnife

Philadelphia, Pennsylvania, United States

Pottstown Memorial Medical Center

Pottstown, Pennsylvania, United States

Cyberknife at Erlanger

Chattanooga, Tennessee, United States

St. Mary's Medical Center

Huntington, West Virginia, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT01885299

Related Trials

Clinical and Genetic Studies of Li-Fraumeni Syndrome

NCT014434682 locations

Collection of Tissue Specimens From Patients With Solid Tumors or Blood Disorders and Their HLA-Compatible Family Members

NCT000710451 location

5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors

NCT033661161 location

Serious Gaming for Chemotherapy-induced Nausea and Vomiting

NCT058386382 locations

Evaluation and Implementation Preparation of a Proactive Palliative Care Model (ENABLE-SG)

NCT060444411 location